Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIPARK-I: Opicapone in Parkinson's Disease
NCT01568073Phase 3Completed
- Sponsor
- BIAL
- Start
- Mar 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of opicapone in Parkinson's disease (PD), sponsored by BIAL. Started Mar 2011; status: completed.
02
Drugs
opicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01568073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01568073.